164 related articles for article (PubMed ID: 37293163)
41. A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers.
Zhang G; Wu B; Fu L; Liu B; Han X; Wang J; Zhang Y; Yu M; Ma H; Ma S; Cai H
Front Genet; 2022; 13():1063119. PubMed ID: 36568401
[No Abstract] [Full Text] [Related]
42. ERRα promotes pancreatic cancer progression by enhancing the transcription of PAI1 and activating the MEK/ERK pathway.
Liu SL; Wu XS; Li FN; Yao WY; Wu ZY; Dong P; Wang XF; Gong W
Am J Cancer Res; 2020; 10(11):3622-3643. PubMed ID: 33294258
[TBL] [Abstract][Full Text] [Related]
43. A positive feedback loop of LINC00662 and STAT3 promotes malignant phenotype of glioma.
Ji W; Jiao J; Cheng C; Xiao Y; Shao J; Liu H
Pathol Res Pract; 2021 Aug; 224():153539. PubMed ID: 34246852
[TBL] [Abstract][Full Text] [Related]
44. METTL3 restrains papillary thyroid cancer progression via m
He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA LINC00662 promotes proliferation and migration in oral squamous cell carcinoma.
Xu D; Chen Y; Yuan C; Zhang S; Peng W
Onco Targets Ther; 2019; 12():647-656. PubMed ID: 30705593
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients.
Li Y; Huang H; Zhu Y; Xu B; Chen J; Liu Y; Zheng X; Chen L
World J Surg Oncol; 2022 Sep; 20(1):283. PubMed ID: 36058919
[TBL] [Abstract][Full Text] [Related]
47. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2.
Wang J; He Z; Liu X; Xu J; Jiang X; Quan G; Jiang J
Cell Death Dis; 2022 Aug; 13(8):718. PubMed ID: 35977942
[TBL] [Abstract][Full Text] [Related]
48. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.
Lin C; Wang Y; Dong Y; Lai S; Wang L; Weng S; Zhang X
Biol Direct; 2022 Nov; 17(1):33. PubMed ID: 36397058
[TBL] [Abstract][Full Text] [Related]
49. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
50. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m
Xu QC; Tien YC; Shi YH; Chen S; Zhu YQ; Huang XT; Huang CS; Zhao W; Yin XY
Oncogene; 2022 Mar; 41(11):1622-1633. PubMed ID: 35094011
[TBL] [Abstract][Full Text] [Related]
51. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
52. RPL21 interacts with LAMP3 to promote colorectal cancer invasion and metastasis by regulating focal adhesion formation.
Zhu J; Long T; Gao L; Zhong Y; Wang P; Wang X; Li Z; Hu Z
Cell Mol Biol Lett; 2023 Apr; 28(1):31. PubMed ID: 37062845
[TBL] [Abstract][Full Text] [Related]
53. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
[TBL] [Abstract][Full Text] [Related]
54. N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.
Guo Y; Feng L
Arch Biochem Biophys; 2022 Oct; 729():109381. PubMed ID: 36027936
[TBL] [Abstract][Full Text] [Related]
55. Silencing linc00662 inhibits cell proliferation and colony formation of lung cancer cells via regulating the miR-145-5p-PAFAH1B2 axis.
Xu ZY; Peng J; Shi ZZ; Chen XL; Cheng HZ; Wang H; Wang Y; Wang GP; Jiang W; Peng H
Biochem Cell Biol; 2021 Jun; 99(3):330-338. PubMed ID: 33108738
[TBL] [Abstract][Full Text] [Related]
56. m
Ji F; Lu Y; Chen S; Lin X; Yu Y; Zhu Y; Luo X
Mol Ther Oncolytics; 2021 Sep; 22():574-581. PubMed ID: 34589576
[TBL] [Abstract][Full Text] [Related]
57. LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1α axis in ovarian cancer.
Tao LM; Gong YF; Yang HM; Pei JH; Zhao XJ; Liu SS
J Biol Regul Homeost Agents; 2020; 34(3):467-477. PubMed ID: 32476381
[TBL] [Abstract][Full Text] [Related]
58. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.
Jiang Z; Song X; Wei Y; Li Y; Kong D; Sun J
Bioengineered; 2022 Jun; 13(6):14460-14471. PubMed ID: 35758158
[TBL] [Abstract][Full Text] [Related]
59. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
